Boston Scientific financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$5.62B $6.28B $7.82B $8.36B $8.05B $8.19B $7.81B $7.62B $7.25B $7.07B $7.31B $7.48B $8.39B $9.05B $9.82B $10.74B $9.91B $11.89B $12.68B $14.24B $0.00M
GM % Gross Margin %
73.38% 74.09% 71.93% 69.58% 67.02% 66.82% 64.95% 63.33% 65.60% 68.30% 69.68% 70.90% 70.82% 71.20% 71.19% 71.09% 68.53% 68.37% 68.44% 69.16% 0.00%
OM Operating Margin
30.48% 32.21% 19.09% 14.37% 16.09% 15.96% 13.36% 13.49% 13.17% 12.83% 13.12% 14.48% 16.59% 17.67% 17.55% 17.06% 11.39% 15.34% 16.03% 16.97% 0.00%
EPS Earnings Per Share
$1.82 $1.14 $0.77 $0.81 $0.50 $0.42 $0.45 $0.41 $0.46 $0.84 $0.93 $1.11 $1.26 $1.47 $1.58 $0.96 $1.63 $1.71 $2.01 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
844.48m 819.48m 1473.96m 1490.79m 1501.52m 1510.43m 1520.08m 1481.51m 1372.98m 1335.22m 1326.49m 1345.2m 1361.68m 1373.2m 1383.8m 1393.82m 1431.92m 1424.99m 1429.45m 1464.98m 1464.98m
OCF Operating Cash Flow
$1.80B $903.00M $1.85B $934.00M $1.22B $835.00M $325.00M $1.01B $1.28B $1.11B $1.27B $691.00M $1.18B $1.43B $310.00M $1.84B $1.51B $1.87B $1.53B $2.50B $0.00M
FCF Free Cash Flow
$1.53B $562.00M $1.50B $571.00M $854.00M $523.00M $53.00M $720.00M $1.03B $837.00M $1.01B $353.00M $1.61B $1.73B $-6.00M $1.38B $1.13B $1.32B $938.00M $2.06B $0.00M
FCFS Free Cash Flow Per Share
$1.83 $0.68 $1.18 $0.38 $0.57 $0.35 $0.03 $0.47 $0.75 $0.64 $0.76 $0.33 $0.59 $0.81 $-0.00 $1.03 $0.84 $0.94 $0.67 $1.23 $0.00